ReviewPharmaceuticals (Basel, Switzerland)2026
Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications.
Ploutarchos Pastras et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.